Cerebrovascular Complications of Pregnancy and the Postpartum Period

Current Cardiology Reports

Volumn 16, Issue 10, 2014, Pages

  Razmara, Ali ^a   Bakhadirov, Khamid ^a   Batra, Ayush ^b   Feske, Steven K ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cerebral venous thrombosis; Cerebrovascular complications; Hemorrhagic stroke; Ischemic stroke; Postpartum period; Pre eclampsia eclampsia; Pregnancy

Indexed keywords

MAGNESIUM SULFATE; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN RADIOGRAPHY; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG EFFECT; FUNCTIONAL DISEASE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; PREGNANCY; PUERPERIUM; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TREATMENT PLANNING; CEREBROVASCULAR DISORDERS; FEMALE; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; TREATMENT OUTCOME;

CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; TREATMENT OUTCOME;

EID: 84919941116     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-014-0532-1     Document Type: Review

References (55)

1. Center for Disease Control. http://www.cdc.gov/nchs/fastats/deaths.htm.
2. Center for Disease Control. http://www.cdc.gov/stroke/facts.htm.
3. Lanska DJ, Kryscio RJ. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology. 1998;51:1622–8.
4. Jaigobin C, Silver FL. Stroke and pregnancy. Stroke. 2000;31:2948–51.
5. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106:509–16.
6. Grear KE, Bushnell CD. Stroke and pregnancy: clinical presentation, evaluation, treatment, and epidemiology. Cinical Obstet Gynecol. 2013;56:350–9.
7. Kittner SJ et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768–74.
8. Kuklina EV, Tong X, Bansil P, et al. Trends in pregnancy hospitalizations that included stroke in the United States from 1994 to 2007. Stroke. 2011;42:2564–70. Discusses trends in pregnancy hospitalizations that included stroke in the United States.
9. Lin SY, Hu CJ, Lin HC. Increased risk of stroke inpatients who undergo cesarean delivery: a nationwide population-based study. Am J Obstet Gynecol. 2008;198:391.e391–7.
10. Nelson JA, Livingston GK, Moon RG. Mutagenic evaluation of radiographic contrast media. Invest Radiol. 1982;17:183–5.
11. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234–40.
12. Colletti PM, Lee KH, Elkayam U. Cardiovascular imaging of the pregnant patient. AJR Am J Roentgenol. 2013;200:515–21. doi:10.2214/AJR.12.9864.
13. De Keyser J, Gdovinova Z, Uyttenboogaart M, et al. Intravenous alteplase for stroke. Beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612–8.
14. Johnson DM et al. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke. 2005;36:e53–5. doi:10.1161/01.str.0000166203.27135.27.
15. Elford K, Leader A, Wee R, Stys PK. Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology. 2002;59:1270–2. doi:10.1212/01.wnl.0000032492.77156.35.
16. Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke. 2006;37:2168–9. doi:10.1161/01.STR.0000230286.95513.c2.
17. Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis. 2002;13:290.
18. Ritter ML et al. Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol. 2014;261:632–4.
19. Hori H et al. Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency. Rinsho Shinkeigakyu. 2013;53:212–6.
20. Yamaguchi Y, Kondo T, Ihara M, et al. Intravenous recombinant tissue plasminogen activator in an 18-week pregnant woman with embolic stroke. Rinsho Shinkeigaku. 2010;50:315–9.
21. Tassi R et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med. 2013;31:448.e441–3.
22. Li Y, Margraf J, Kluck B, Jenny D, Castaldo J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review. Neurologist. 2012;18:44–8.
23. Coomarasamy A, Honest H, Papaioannou S, et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systemic review. Obstet Gynecol. 2003;101:1319–32.
24. Furie KL et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227–76. doi:10.1161/STR.0b013e3181f7d043. Updated AHA/ASA guidelines for the prevention of stroke in patients with stroke or transient ischemic attack.
25. Abalos E et al. WHO Multicounty Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicounty Survey on Maternal and Newborn Health. Br J Gynecol. 2014;121 Suppl 1:14–24.
26. Feske SK, Singhal A. Cerebrovascular disorders complicating pregnancy. Continuum. 2014;20:80–99.
27. Brewer J et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013;208:468.e461–6.
28. Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30:1371–9.
29. Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004;61:411–6.
30. Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int. 2014.
31. Beausang-Linder M, Anders B. Cerebral circulation in acute arterial hypertension—protective effects of sympathetic nervous activity. Acta Physiol Scand. 1981;111:193–9.
32. Singhal AB et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol. 2011;68:1005–12. doi:10.1001/archneurol.2011.68.
33. Pregnany, T. F. o. H. i. Hypertension and pregnancy: establishing the diagnosis of preeclampsia and eclampsia. Am J Obstet Gynecol.2013; 17–20.
34. Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol. 2011;11:136–44.
35. Weier K, Fluri F, Kos S, Gass A. Postcontrast FLAIR MRI demonstrates blood-brain barrier dysfunction in PRES. Neurology. 2009;72:760–2.
36. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205–10.
37. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Syst Rev. 2003;2, CD000025.
38. Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology. 2007;69:894–7.
39. Fugate JE et al. Fulminant postpartum cerebral vasoconstriction syndrome. Arch Neurol. 2012;69:111–7.
40. Liang CC et al. Stroke complicating pregnancy and the puerperium. Eur J Neurol. 2006;13:1256–60.
41. Feske SK, Klein AM. Clinical risk factors predict pregnancy-associated strokes. Stroke. 2009;40:e183–4.
42. Bousser M-G. Cerebral venous thrombosis: diagnosis and management. J Neurol. 2000;247:252–8.
43. Coutinho J, de Bruijn SFTM, deVeber G, Stam, J. Anticoagulation for cerebral venous sinus thrombosis (review). Cochrane Database Syst Rev. 2011; CD002005.
44. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600.
45. de Bruijn SF, Stam J, Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight-heparin for cerebral sinus thrombosis. Stroke. 1999;30:484–8.
46. Kamel H et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–15. doi:10.1056/NEJMoa1311485.
47. Sharshar T, Lamy C, Mas JL, Stroke in Pregnancy Study Group. Incidence and causes of stroke associated with pregnancy and puerperium: a study in public hospitals of Ile de France. Stroke. 1995;26:930–6.
48. Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990;27:855–65.
49. Meyers PM et al. Endovascular treatment of cerebral artery aneurysms during pregnancy: report of three cases. AJNR Am J Neuroradiol. 2000;21:1306–11.
50. Robinson JL, Hall CS, Sedzimir CB. Arteriovenous malformations, aneurysms, and pregnancy. J Neurosurg. 1974;41:63–70.
51. Horton JC, Chambers WA, Lyons SL, Adams RD, Kjellberg RN. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1990;27:867–72.
52. Parkinson D, Bachers G. Arteriovenous malformations: summary of 100 consecutive supratentorial cases. J Neurosurg. 1980;53:285–99.
53. Wier B, MacDonald RL. Neurosurg (eds R. H. Wilkins & S. S. REngachary) 2421–2427 (McGraw-Hill, 1996).
54. Sawin P. Neurol Asp pregnancy. (ed C. Loftus) 85–99 (American Association of Neurological Surgeons, 1996).
55. Ogilvy CS et al. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals for a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32:1458–71. doi:10.1161/01.STR.32.6.1458.